X @Bloomberg
Bloomberg·2026-03-10 09:56
Swiss generic drugmaker Sandoz Group AG has created a global biosimilars unit to capitalize on drugs worth $650 billion losing patent protection over the next decade https://t.co/98uyAFhLJP ...
Swiss generic drugmaker Sandoz Group AG has created a global biosimilars unit to capitalize on drugs worth $650 billion losing patent protection over the next decade https://t.co/98uyAFhLJP ...